Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders
View ORCID ProfileMarton König, Hilde Marie Torgauten, Mathias Herstad Øverås, Adity Chopra, Åslaug Rudjord Lorentzen, The Trung Tran, View ORCID ProfileSiri Mjaaland, View ORCID ProfileIngeborg Sundsvalen Aaberge, View ORCID ProfileKjell-Morten Myhr, View ORCID ProfileStig Wergeland, View ORCID ProfileTone Berge, View ORCID ProfileHanne Flinstad Harbo, Øivind Fredvik Torkildsen, Trygve Holmøy, View ORCID ProfileElisabeth Gulowsen Celius, View ORCID ProfileLudvig Andre Munthe, View ORCID ProfileJohn Torgils Vaage, View ORCID ProfileFridtjof Lund-Johansen, View ORCID ProfileGro Owren Nygaard
doi: https://doi.org/10.1101/2021.10.15.21264977
Marton König
1Oslo University Hospital, Department of Neurology, Oslo, Norway
Hilde Marie Torgauten
2Neuro-SysMed, Department of Neurology, Haukeland University Hospital
3University of Bergen, Department of Clinical Medicine
Mathias Herstad Øverås
1Oslo University Hospital, Department of Neurology, Oslo, Norway
Adity Chopra
4Oslo University Hospital, Department of Immunology, Oslo, Norway
Åslaug Rudjord Lorentzen
5Sørlandet Hospital, Department of Neurology, Kristiansand, Norway
6Sørlandet Hospital, The Norwegian National Advisory Unit on Tick-borne diseases, Arendal, Norway
The Trung Tran
4Oslo University Hospital, Department of Immunology, Oslo, Norway
Siri Mjaaland
7Norwegian Institute of Public Health, Division of Infection Control, Oslo, Norway
Ingeborg Sundsvalen Aaberge
7Norwegian Institute of Public Health, Division of Infection Control, Oslo, Norway
Kjell-Morten Myhr
2Neuro-SysMed, Department of Neurology, Haukeland University Hospital
3University of Bergen, Department of Clinical Medicine
Stig Wergeland
2Neuro-SysMed, Department of Neurology, Haukeland University Hospital
8Norwegian MS Registry and Biobank, Haukeland University Hospital, Bergen, Norway
Tone Berge
9Oslo Metropolitan University, Department of Mechanical, Electronic and Chemical Engineering, Oslo, Norway
10Oslo University Hospital, Department of Research, Innovation and Education, Division of Clinical Neuroscience, Oslo, Norway
Hanne Flinstad Harbo
1Oslo University Hospital, Department of Neurology, Oslo, Norway
11University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Øivind Fredvik Torkildsen
2Neuro-SysMed, Department of Neurology, Haukeland University Hospital
3University of Bergen, Department of Clinical Medicine
Trygve Holmøy
11University of Oslo, Institute of Clinical Medicine, Oslo, Norway
12Akershus University Hospital, Department of Neurology, Oslo, Norway
Elisabeth Gulowsen Celius
1Oslo University Hospital, Department of Neurology, Oslo, Norway
11University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Ludvig Andre Munthe
4Oslo University Hospital, Department of Immunology, Oslo, Norway
13University of Oslo, KG Jebsen Centre for B cell malignancy, Oslo, Norway
John Torgils Vaage
4Oslo University Hospital, Department of Immunology, Oslo, Norway
Fridtjof Lund-Johansen
4Oslo University Hospital, Department of Immunology, Oslo, Norway
Gro Owren Nygaard
1Oslo University Hospital, Department of Neurology, Oslo, Norway

Data Availability
All data produced in the present study are available upon reasonable request to the authors All data produced in the present work are contained in the manuscript.
Posted October 18, 2021.
Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders
Marton König, Hilde Marie Torgauten, Mathias Herstad Øverås, Adity Chopra, Åslaug Rudjord Lorentzen, The Trung Tran, Siri Mjaaland, Ingeborg Sundsvalen Aaberge, Kjell-Morten Myhr, Stig Wergeland, Tone Berge, Hanne Flinstad Harbo, Øivind Fredvik Torkildsen, Trygve Holmøy, Elisabeth Gulowsen Celius, Ludvig Andre Munthe, John Torgils Vaage, Fridtjof Lund-Johansen, Gro Owren Nygaard
medRxiv 2021.10.15.21264977; doi: https://doi.org/10.1101/2021.10.15.21264977
Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders
Marton König, Hilde Marie Torgauten, Mathias Herstad Øverås, Adity Chopra, Åslaug Rudjord Lorentzen, The Trung Tran, Siri Mjaaland, Ingeborg Sundsvalen Aaberge, Kjell-Morten Myhr, Stig Wergeland, Tone Berge, Hanne Flinstad Harbo, Øivind Fredvik Torkildsen, Trygve Holmøy, Elisabeth Gulowsen Celius, Ludvig Andre Munthe, John Torgils Vaage, Fridtjof Lund-Johansen, Gro Owren Nygaard
medRxiv 2021.10.15.21264977; doi: https://doi.org/10.1101/2021.10.15.21264977
Subject Area
Subject Areas
- Addiction Medicine (160)
- Allergy and Immunology (413)
- Anesthesia (90)
- Cardiovascular Medicine (855)
- Dermatology (97)
- Emergency Medicine (248)
- Epidemiology (8550)
- Gastroenterology (383)
- Genetic and Genomic Medicine (1744)
- Geriatric Medicine (167)
- Health Economics (371)
- Health Informatics (1237)
- Health Policy (619)
- Hematology (196)
- HIV/AIDS (372)
- Medical Education (192)
- Medical Ethics (51)
- Nephrology (210)
- Neurology (1670)
- Nursing (97)
- Nutrition (248)
- Oncology (926)
- Ophthalmology (263)
- Orthopedics (100)
- Otolaryngology (172)
- Pain Medicine (112)
- Palliative Medicine (40)
- Pathology (252)
- Pediatrics (534)
- Primary Care Research (207)
- Public and Global Health (3832)
- Radiology and Imaging (622)
- Respiratory Medicine (520)
- Rheumatology (207)
- Sports Medicine (157)
- Surgery (190)
- Toxicology (36)
- Transplantation (101)
- Urology (74)